Home

Evoke Pharma, Inc. - Common Stock (EVOK)

10.69
+0.03 (0.28%)
NASDAQ · Last Trade: Nov 5th, 6:31 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. (NYSE - KVUE), Sonida Senior Living, Inc. (NYSE - SNDA), Evoke Pharma Inc. (Nasdaq - EVOK), SM Energy Company (NYSE - SM)
BALA CYNWYD, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · November 5, 2025
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Evoke Pharma, Inc. (NASDAQ: EVOK) to QOL Medical, LLC for $11.00 per share in cash is fair to Evoke shareholders.
By Halper Sadeh LLC · Via Business Wire · November 4, 2025